OUTCOME OF PATIENTS ADMITTED WITH ACUTE LOWER EXTREMITY ISCHEMIA

Completed

• Conditions: Acute Ischemia of Lower Limb
• Interventions: Procedure: operation of ischemia of the lower limbs

• Registration Number: NCT05255640
• Lead Sponsor: Centre Hospitalier Universitaire de Nice

Brief Summary

Acute ischemia of the lower limb (AMI) is a life-threatening emergency that threatens the functional prognosis of the limb. Depending on the clinical presentation and the anatomy of the patient, several therapeutic approaches can be considered: open surgery, endovascular surgery, hybrid surgery or amputation if revascularization is not feasible. The data in the current literature do not allow to clearly establish which therapeutic approach is the most adapted to the patient.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-02-15
• Study First Submitted QC: 2022-02-15
• Study First Posted: 2022-02-24
• Study Start: 2022-03-04
• Primary Completion: 2023-11-09
• Study Completion: 2023-11-09
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-26
• Last Update Posted: 2024-06-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 176

Inclusion Criteria

• Age greater than 18 years, regardless of gender.
• Diagnosis of AMI defined according to the Rutherford classification (2). AMI may involve one or both lower limbs.
• Be able to understand and give free and informed consent (non-opposition) to participate in the study
• To be affiliated to the social security system
• Not to object to participating in the study (collection of non-objection)

Exclusion Criteria

• Voluntary discharge of the patient: opposition to the use of the data (withdrawal of the non-objection)
• Termination of the study by decision of the sponsor or investigator.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
patients with ischemia of the lower limbs	operation of ischemia of the lower limbs	-

Primary Outcome Measures

Name	Time	Method
survival	90 days

Trial Locations

Locations (14)

Besançon university hospital; 🇫🇷 Besançon, France

Bordeaux University Hospital; 🇫🇷 Bordeaux, France

Brest University Hospital; 🇫🇷 Brest, France

Dijon University Hospital; 🇫🇷 Dijon, France

Lyon University Hospital; 🇫🇷 Lyon, France

Nancu University Hospital; 🇫🇷 Nancy, France

Nantes University Hospital; 🇫🇷 Nantes, France

Nice University Hospital; 🇫🇷 Nice, France

APHP - Hôpital Mondor; 🇫🇷 Paris, France

APHP- Ambroise Paré; 🇫🇷 Paris, France

APHP- Hôpital Bichat; 🇫🇷 Paris, France

APHP- Hôpital Européen Georges Pompidou; 🇫🇷 Paris, France

Reims University Hospital; 🇫🇷 Reims, France

Strasbourg University Hospital; 🇫🇷 Strasbourg, France